Gyoda, Japan

Chihiro Yokoo


 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Saitama, JP (1982)
  • Gyoda, JP (1980 - 1994)
  • Tokyo, JP (1998 - 2007)

Company Filing History:


Years Active: 1980-2007

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Chihiro Yokoo: Innovator in Pharmaceutical Chemistry

Introduction

Chihiro Yokoo is a prominent inventor based in Gyoda, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, Yokoo has made remarkable advancements in the field, particularly in the synthesis of novel compounds with therapeutic applications.

Latest Patents

Yokoo's latest patents include a method for the production of cis-4-fluoro-L-proline derivatives. This invention provides a safer and more efficient method for producing these derivatives under milder conditions, resulting in high-purity products at a lower cost on an industrial scale. Another notable patent involves the development of novel steroid derivatives that exhibit antitumor action. These steroid derivatives can be synthesized efficiently and stereoselectively through advanced synthetic organic chemistry techniques.

Career Highlights

Chihiro Yokoo is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has not only advanced the field of medicinal chemistry but has also paved the way for new therapeutic options for patients.

Collaborations

Yokoo has collaborated with esteemed colleagues, including Yoshiaki Watanabe and Akira Onodera, to further enhance the scope of his research and development efforts.

Conclusion

Chihiro Yokoo's innovative work in pharmaceutical chemistry has led to significant advancements in the synthesis of important compounds. His contributions continue to impact the industry positively, showcasing the importance of research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…